Bortezomib - - bor-TEZ-oh-mib belongs to the general group of medication known as antineoplastics. It is using to treat multiple myeloma in diseaseds who have received other treats that have not helped.
Bortezomib interferes with the growth of cancer cells, which are then eventually destroyed by the body. Since the growth of normal body cells may also be effected by bortezomib, other effects will also occur. Some of these may be serious and must be reported to your family doctor. Other effects may not be serious but may cause concern. Some effects may not occur until months or years after the drug is using.
Bortezomib is to be aplaying only by or under the supervision of your family doctor. It is available in the following dosage form:
Some commonly using brand names are:
In the USA
† Not commercially available in Canada.